Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment?

Author： von Moos Roger   Haynes Ian  

Publisher： MDPI

E-ISSN： 2077-0383|2|3|89-102

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.2, Iss.3, 2013-08, pp. : 89-102

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases

By Simos Demetrios   Addison Christina L.   Kuchuk Iryna   Hutton Brian   Mazzarello Sasha   Clemons Mark  

Journal of Clinical Medicine, Vol. 2, Iss. 3, 2013-08 ,pp. : 67-88

MDPI

Access to resources Recommend Favorite

Bone Targeted Therapies for Bone Metastasis in Breast Cancer

By Razaq Wajeeha  

Journal of Clinical Medicine, Vol. 2, Iss. 4, 2013-10 ,pp. : 176-187

MDPI

Access to resources Recommend Favorite

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

By Bignucolo Alessia   De Mattia Elena   Cecchin Erika   Roncato Rossana   Toffoli Giuseppe  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1522-1522

MDPI

Access to resources Recommend Favorite

Prevention and Treatment of Bone Metastases in Breast Cancer

By Ripamonti Carla   Trippa Fabio   Barone Gloria   Maranzano Ernesto  

Journal of Clinical Medicine, Vol. 2, Iss. 3, 2013-09 ,pp. : 151-175

MDPI

Access to resources Recommend Favorite

Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment

By Zhang Yilong   Jain Rajul K.   Zhu Min  

Biomedicines, Vol. 3, Iss. 1, 2015-03 ,pp. : 149-181

MDPI

Access to resources Recommend Favorite